Maxcyte (MXCT) Depreciation and Depletion (2024 - 2026)

Maxcyte (MXCT) has 3 years of Depreciation and Depletion data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Depreciation and Depletion fell 5.16% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $4.2 million, a 1.38% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, down 0.65% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
• Over the last five years, Depreciation and Depletion for MXCT reached as high as $1.1 million in Q2 2025 and fell as low as $1.0 million in Q1 2026.
• Historically, Depreciation and Depletion has averaged $1.1 million across 3 years, with a median of $1.1 million in 2024.
• Across the five-year window, Depreciation and Depletion increased 0.74% in 2025 and dropped 5.16% in 2026, its largest moves.
• Year by year, Depreciation and Depletion stood at $1.1 million in 2024, then dropped by 0.19% to $1.1 million in 2025, then decreased by 2.37% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.